Đang chuẩn bị liên kết để tải về tài liệu:
báo cáo hóa học:" CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? | Journal of Translational Medicine BioMed Central Open Access CRP identifies homeostatic immune oscillations in cancer patients a potential treatment targeting tool Brendon J Coventry 1 Martin L Ashdown2 Michael A Quinn3 Svetomir N Markovic4 Steven L Yatomi-Clarke5 and Andrew P Robinson6 Address Department of Surgery Tumour Immunology Laboratory University of Adelaide Royal Adelaide Hospital Adelaide South Australia 5000 Australia 2Faculty of Medicine University of Melbourne Parkville Victoria 3052 Australia 3Department of Obstetrics Gynaecology University of Melbourne Royal Womens Hospital Parkville Victoria 3052 Australia 4Melanoma Study Group Mayo Clinic Cancer Center Rochester Minnesota 55905 USA 5Berbay Biosciences West Preston Victoria 3072 Australia and 6Department of Mathematics and Statistics University of Melbourne Parkville Victoria 3052 Australia Email Brendon J Coventry - brendon.coventry@adelaide.edu.au Martin L Ashdown - mlashdown@optusnet.com.au Michael A Quinn - QuinnM@ramsayhealth.com.au SvetomirN Markovic-markovic.svetomir@mayo.edu Steven LYatomi-Clarke - SClarke@psl.com.au Andrew P Robinson - a.Robinson@ms.unimelb.edu.au Corresponding author Published 30 November 2009 Received 28 May 2009 Journal of Translational Medicine 2009 7 102 doi 10.1 186 1479-5876-7-102 Accepted 30 November 2009 This article is available from http www.translational-medicine.cOm content 7 1 102 2009 Coventry et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract_ The search for a suitable biomarker which indicates immune system responses in cancer patients has been long and arduous but a widely known biomarker has emerged as a potential candidate for